Velpanat – Generic Epclusa is a prescription antiviral medication containing Sofosbuvir (400 mg) and Velpatasvir (100 mg), used for the treatment of chronic Hepatitis C virus (HCV) infection across all major genotypes (1–6). It works by preventing the virus from multiplying in the body and is typically taken once daily for 12 weeks, as prescribed by a healthcare professional. Velpanat offers a well-studied, effective, and globally trusted therapeutic option for eligible adults and pediatric patients under medical supervision.
Velpanat – Generic Epclusa is a prescription antiviral medication used for the treatment of chronic Hepatitis C virus (HCV) infection. It contains a fixed-dose combination of Sofosbuvir (400 mg) and Velpatasvir (100 mg), which are direct-acting antiviral agents. This medicine is effective against all major Hepatitis C genotypes (1–6) and is commonly prescribed by healthcare professionals as part of a structured antiviral treatment plan.
What Is Velpanat – Generic Epclusa?
Velpanat is the generic version of Epclusa, a globally approved treatment for Hepatitis C. It is a once-daily oral tablet designed to simplify therapy while maintaining high cure rates. Velpanat is suitable for adults and eligible pediatric patients, including those with or without compensated liver cirrhosis, when taken under medical supervision.
How Velpanat – Generic Epclusa Works
Velpanat works by targeting key proteins required for the Hepatitis C virus to replicate and survive in the body.
Mechanism of Action
Sofosbuvir inhibits the NS5B RNA polymerase enzyme, preventing viral replication
Velpatasvir blocks the NS5A protein, disrupting viral assembly and spread
Helps reduce viral load and supports complete clearance of the virus from the bloodstream
Uses of Velpanat – Generic Epclusa Tablets
Velpanat – Generic Epclusa is used for:
Therapeutic Indications
Treatment of chronic Hepatitis C virus infection
Effective across HCV genotypes 1, 2, 3, 4, 5, and 6
Use in patients with or without compensated cirrhosis
Part of combination therapy in specific advanced liver conditions, as prescribed
Dosage and Administration
The dosage and duration of Velpanat treatment are determined by a qualified healthcare professional based on the patient’s medical condition.
Administration Guidelines
Taken orally once daily
Can be taken with or without food
Swallow the tablet whole with water
Do not skip doses or stop treatment without consulting a doctor
Side Effects of Velpanat – Generic Epclusa
Most patients tolerate Velpanat well, though some side effects may occur.
Common Side Effects
Headache
Fatigue
Nausea
Diarrhea
Less Common Side Effects
Insomnia
Weakness
Mild digestive discomfort
Seek medical attention if severe or persistent side effects occur.
Warnings and Precautions
Before using Velpanat – Generic Epclusa, inform your doctor if you have a history of liver disease, kidney problems, or hepatitis B infection.
Important Safety Information
Hepatitis B screening is recommended before starting treatment
Use during pregnancy or breastfeeding only if prescribed
Inform your doctor about all medications to avoid drug interactions
Not intended for self-medication
Storage Instructions
Store at room temperature below 25°C
Keep away from moisture and direct sunlight
Keep out of reach of children
